Steven Cohen’s Pfizer PFE Stock Holding History

Steven Cohen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.3M	Buy	1,589,300 +728,300	+85%	+$19.1M	0.04%	546
2026 Q1	$24.2M	Buy	861,000 +49,400	+6%	+$1.32M	0.03%	708
2025 Q4	$20.2M	Buy	811,600 +615,700	+314%	+$15.5M	0.02%	883
2025 Q3	$4.99M	Sell	195,900 -33,000	-14%	-$815K	0.01%	1066
2025 Q2	$5.55M	Buy	+228,900	New	+$5.34M	0.01%	934
2019 Q4	–	Sell	-316,200	Closed	-$10.8M	–	1182
2019 Q3	$10.8M	Hold	316,200	–	–	0.07%	346
2019 Q2	$13M	Buy	+316,200	New	+$12.6M	0.07%	337

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Steven Cohen's PFE Position: Q2 2026 in Review

Steven Cohen sold out of Pfizer (PFE) in Q2 2026, closing a stake of 4,365,063 shares — an estimated $114M sold.

Steven Cohen first reported a position in PFE in Q3 2014 and held it in 12 quarters. The position peaked at $123M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Steven Cohen reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 4,365,063 Pfizer shares in Q2 2026, an estimated $114M.
Steven Cohen first reported a position in Pfizer in Q3 2014 and held it in 12 quarters.
Steven Cohen's Pfizer position peaked at $123M in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.